Steven T Olson

Title: The Innovations of Steven T Olson

Introduction

Steven T Olson is an accomplished inventor based in Chicago, IL. He holds 2 patents that contribute significantly to the field of medical science, particularly in thrombolysis and plasminogen research. His work has the potential to enhance therapeutic methods for clot lysis, showcasing his innovative approach to solving complex medical challenges.

Latest Patents

Olson's latest patents include "Peptide mediated enhancement of thrombolysis methods and compositions." This invention focuses on peptides that decrease the half-life of active plasminogen activator inhibitor-1, providing methods and compositions for utilizing these peptides in clot lysis. Another notable patent is "Active site labelling of plasminogen," which involves a plasminogen that has a label incorporated into an active site, rendering it enzymatically and catalytically inactive upon conversion to plasmin. This patent also includes a method for creating a labeled plasminogen and an assay method utilizing this labeled plasminogen.

Career Highlights

Throughout his career, Steven T Olson has worked with reputable organizations such as Henry Ford Health System and the University of Michigan. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Olson's notable coworkers include Joseph D Shore and Daniel Lawrence. Their collaborative efforts have further advanced the research and development of innovative medical solutions.

Conclusion

Steven T Olson's contributions to the field of medical science through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in thrombolysis and plasminogen research, demonstrating the impact of innovation in healthcare.